← Back to Patent Explorer
US4637931A Expired / Lapsed US ⏱️ 0.0 years remaining

Polyactic-polyglycolic acid copolymer combined with decalcified freeze-dried bone for use as a bone repair material

Assignee: United States Department of the Army
•
Filing: 1984-10-09
•
Granted: 1987-01-20
•
Expires: 2004-10-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel bone repair material consisting essential of decalcified freeze-dd bone and biodegradable, biocompatible copolymer has been developed for improving and accelerating the healing of osseous tissue. The bone repair material was prepared by combining decalcified bone with a copolymer consisting essentially of a 50:50 poly(L)(-)lactide co-glycolide.

Inventors

  • 👤 John P. Schmitz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:50
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3641; A61L27/3645; A61L27/365; A61L27/14; A61L27/18; A61L27/3604; A61L27/3608; A61L27/3683

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 43 words
A method for promoting the healing of osseous tissue which comprises implanting at the site of the broken osseous tissue a therapeutically-effective amount of a composition comprising decalcified freeze-dried bone incorporated into a biodegradable polymeric matrix comprised of a copolymer of poly(L)(-)lactide co-glycolide.
Claim 2
Independent Claim 43 words
A method for promoting the healing of osseous tissue which comprises implanting at the site of the broken osseous tissue a therapeutically-effective amount of a composition comprising decalcified freeze-dried bone incorporated into a biodegradable polymeric matrix comprised of a copolymer of poly(L)(-)lactide co-glycolide.
Claim 3
Dependent Claim 19 words
The method of claim 1 wherein said bone is cortical bone which was decalcified in 0.6 normal hydrochloric acid.
Claim 4
Dependent Claim 25 words
The method of claim 1 wherein the amount of the decalcified freeze-dried bone is about 40 to 60 percent by weight of said polymeric matrix.
Claim 5
Dependent Claim 25 words
The method of claim 3 wherein the amount of the decalcified freeze-dried bone is about 45 to 55 percent by weight of said polymeric matrix.
Claim 6
Dependent Claim 20 words
The method of claim 4 wherein the amount of decalcified freeze-dried bone is about 50 percent of said polymeric matrix.
Claim 7
Dependent Claim 12 words
The method of claim 1 wherein the copolymer is 50:50 poly(L)(-)lactide co-glycolide.
Claim 8
Dependent Claim 19 words
The method of claim 6 wherein the amount of decalcified freeze-dried bone is about 50 percent of said copolymer.
Claim 9
Dependent Claim 22 words
The method of claim 7 wherein the decalcified freeze-dried bone has a particle size in the range of 149 to 590 μm.
Claim 10
Dependent Claim 21 words
The method of claim 8 wherein the decalcified freeze-dried bone has a particle size in the range of 200 to 400μm.
Claim 11
Dependent Claim 37 words
The method of claim 2 wherein the amount of decalcified freeze-dried bone, having a particle size in the range of 200 to 400 μm, is about 50 percent by weight and the copolymer is 50:50 poly(L)(-)lactide co-glycolide.
Claim 12
Dependent Claim 29 words
A pharmaceutical composition useful in promoting the healing of broken osseous tissue comprising decalcified freeze-dried bone incorporated into a biodegradable polymeric matrix comprised of a copolymer of poly(L)(-)lactide co-glycolide.
Claim 13
Dependent Claim 29 words
A pharmaceutical composition useful in promoting the healing of broken osseous tissue comprising decalcified freeze-dried bone incorporated into a biodegradable polymeric matrix comprised of a copolymer of poly(L)(-)lactide co-glycolide.
Claim 14
Dependent Claim 19 words
The composition of claim 11 wherein said bone is cortical bone which was decalcified in 0.6 normal hydrochloric acid.
Claim 15
Dependent Claim 24 words
The composition of claim 12 wherein the amount of decalcified freeze-dried bone is about 40 to 60 percent by weight of said polymeric matrix.
Claim 16
Dependent Claim 24 words
The composition of claim 13 wherein the amount of decalcified freeze-dried bone is about 45 to 55 percent by weight of said polymeric matrix.
Claim 17
Dependent Claim 22 words
The composition of claim 14 wherein the amount of decalcified freeze-dried bone is about 50 percent by weight of said polymeric matrix.
Claim 18
Dependent Claim 12 words
The composition of claim 15 wherein the copolymer is 50:50 poly(L)(-)lactide co-glycolide.
Claim 19
Dependent Claim 22 words
The composition of claim 16 wherein the decalcified freeze-dried bone has a particle size in the range of 149 to 590 μm.
Claim 20
Dependent Claim 22 words
The composition of claim 16 wherein the decalcified freeze-dried bone has a particle size in the range of 200 to 400 μm.
Claim 21
Dependent Claim 32 words
The composition of claim 18 wherein said bone is cortical bone which was decalcified in 0.6 normal hydrochloric acid, and incorporated into said copolymer in the amount of 50 percent by weight.

References Cited (Backward Citations)

US4172128A Cited
US4440750A Cited
US4526909A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-01-19 1990-07-21 1991-01-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-01-19 1994-07-21 1995-01-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-01-19 1998-07-21 1999-01-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag